Crossmark

Immune checkpoint and angiogenic inhibitors for the treatment of hepatocellular carcinoma: It takes two to tangle

Crossref DOI link: https://doi.org/10.1016/j.aohep.2022.100740

Published Print: 2022-09

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Sukowati, Caecilia

Cabral, Loraine Kay D.

Tiribelli, Claudio
Funding

Funding for this research was provided by:

Department of Science and Technology, Ministry of Science and Technology, India

Fondazione Umberto Veronesi

Department of Science and Technology, Philippines

Philippine Council for Health Research and Development
License Information

Text and Data Mining valid from 2022-09-01

Text and Data Mining valid from 2022-09-01

Version of Record valid from 2022-06-28
More Information

This article is maintained by: Elsevier

Article Title: Immune checkpoint and angiogenic inhibitors for the treatment of hepatocellular carcinoma: It takes two to tangle

Journal Title: Annals of Hepatology

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.aohep.2022.100740

Content Type: article

Copyright: © 2022 Fundación Clínica Médica Sur, A.C. Published by Elsevier España, S.L.U.